Impact of Cardiometabolic Risk Factor Burden and Therapeutic Control on the Prognosis of Alcohol-Related Hepatitis: A Biopsy-Proven Cohort Study With External Multicentre Validation.
BACKGROUND AND AIMS Cardiometabolic risk factors (CMRF) have traditionally been overlooked in alcohol-related liver disease (ALD) and their prognostic impact in alcohol-related hepatitis (AH) remains poorly defined. We evaluated the influence of CMRF burden and therapeutic control on complications and mortality in AH....